Western States Biopharmaceuticals, Inc. was founded in January 2009 and is a privately-held firm based on intellectual property from the University of Colorado Denver, Anschutz Medical Center.

Western States is located in the Bioscience Park Center at the Colorado Science + Technology Park at Fitzsimons in Aurora, Colorado. It is adjacent to the University of Colorado Anschutz Medical Campus and the laboratories of our co-founder and two of our scientific advisory board members.

Our mission is to develop and commercialize novel therapies that selectively modulate adaptive immunity to treat inflammatory diseases.

Our products are based on our discovery of TCISMs, proteins that selectively regulate the adaptive immune process. Blocking TCISMs can stop the destructive cytokines that lead to disability in inflammatory diseases.